Evidence map›Paper›PMID 28138557›Full record

ArticleJCI insight2017

Characterization of miRNA-regulated networks, hubs of signaling, and biomarkers in obstruction-induced bladder dysfunction.

Ali Hashemi Gheinani, Bernhard Kiss, Felix Moltzahn, Irene Keller, Rémy Bruggmann, Hubert Rehrauer, Catharine Aquino Fournier, Fiona C Burkhard, Katia Monastyrskaya

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ali Hashemi GheinaniUrology Research Laboratory, Department of Clinical Research, University of Bern, Bern, Switzerland.
Bernhard KissDepartment of Urology, University Hospital, Bern, Switzerland.
Felix MoltzahnDepartment of Urology, University Hospital, Bern, Switzerland.
Irene KellerInterfaculty Bioinformatics Unit, University of Bern, Bern, Switzerland.
Rémy BruggmannInterfaculty Bioinformatics Unit, University of Bern, Bern, Switzerland.
Hubert RehrauerFunctional Genomics Center Zurich, Zurich, Switzerland.
Catharine Aquino FournierFunctional Genomics Center Zurich, Zurich, Switzerland.
Fiona C BurkhardDepartment of Urology, University Hospital, Bern, Switzerland.
Katia MonastyrskayaUrology Research Laboratory, Department of Clinical Research, University of Bern, Bern, Switzerland.
University of Bern · CHUniversity Hospital of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bladder outlet obstruction (BOO) induces significant organ remodeling, leading to lower urinary tract symptoms accompanied by urodynamic changes in bladder function. Here, we report mRNA and miRNA transcriptome sequencing of bladder samples from human patients with different urodynamically defined states of BOO. Patients' miRNA and mRNA expression profiles correlated with urodynamic findings. Validation of RNA sequencing results in an independent patient cohort identified combinations of 3 mRNAs (NRXN3, BMP7, UPK1A) and 3 miRNAs (miR-103a-3p, miR-10a-5p, miR-199a-3p) sufficient to discriminate between bladder functional states. All BOO patients shared cytokine and immune response pathways, TGF-β and NO signaling pathways, and hypertrophic PI3K/AKT signaling pathways. AP-1 and NFkB were dominant transcription factors, and TNF-α was the top upstream regulator. Integrated miRNA-mRNA expression analysis identified pathways and molecules targeted by differentially expressed miRNAs. Molecular changes in BOO suggest an increasing involvement of miRNAs in the control of bladder function from the overactive to underactive/acontractile states.

Indexed as

AgedAged, 80 and overBiomarkersBone Morphogenetic Protein 7Case-Control StudiesCytokinesGene Expression ProfilingGene Regulatory NetworksHumansMaleMetabolic Networks and PathwaysMicroRNAsMiddle AgedNerve Tissue ProteinsNF-kappa BNitric OxideBiomarkersBMP7 protein, humanBone Morphogenetic Protein 7CytokinesMicroRNAsMIRN103 microRNA, humanMIRN10 microRNA, humanmirn199 microRNA, humanNerve Tissue Proteinsneurexin IIIalphaNF-kappa BNitric OxidePhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRNA, MessengerTranscription Factor AP-1Transforming Growth Factor betaUPK1A protein, humanUroplakin Ia

Identifiers

PMID28138557
PMCPMC5256140
OpenAlexW2580426837

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.